FEATURES OF THE APPLICATION OF DIAGNOSTIC IMAGING METHODS IN EVALUATING THE RESULTS OF TREATMENT OF BONE METASTASES

Sergeev N. I., Kotlyarov P. M., Teplyakov V.V., Solodkiy V. A.

The article presents a comparative analysis of imaging methods in evaluating the results of treatment of bone metastases.

Purpose. The formation of a diagnostic protocol for evaluating the special treatment of bone metastases, taking into account the peculiarities of imaging, depending on the type of treatment used.

Material and methods. The data of X-ray, multispiral and magnetic resonance imaging of 90 patients with bone metastases were analyzed, including with the threat/pathological fractures of the long bones and vertebrae that underwent drug therapy, systemic or remote radiation therapy, various types of oncopedic benefits.

Results.Based on the analysis and static data processing, the advantages and disadvantages of the studied methods are determined for various types of special treatment. In addition, the study showed that, depending on the somatic status of the patient, the nature of the metastatic lesion, the information content of the diagnostic methods can differ significantly. In this regard, we consider it necessary to separate the amount of diagnostic methods performed, which eliminates duplicate studies and reduces the time before treatment begins.

Conclusion. A systematic approach is proposed in the use of diagnostic methods using a three-level examination protocol depending on the current clinical tasks.

Russian Scientific Center of Roentgenoradiology. Moscow, Russia.

 

Keywords:  oncology, bone metastases, radiation diagnostics, MRI, CT, special treatment.

 


Corresponding author: Sergeev N. I., e-mail:  Этот e-mail адрес защищен от спам-ботов, для его просмотра у Вас должен быть включен Javascript

 

For citation: Zolotenkova G.V., Poletaeva M.P., Gulgeldiev G.G., Narina N.V, Serova N.S. Radiological features of age changes in the cricoid and arytenoid human larynx cartilages. REJR 2021; 11(4):84-93. DOI: 10.21569/2222-7415-2021-11-4-84-93.

Received:        25.12.19 Accepted:       23.09.21